ScoutQuest22 Oct 2026
Clinitech Laboratory544220RPT disclosure

Certificate confirms related party transaction rules do not apply for half year ended September 30, 2026

Clinitech Laboratory has told BSE that Regulation 23 of SEBI (LODR) Regulations, 2015, which governs related party transactions, is not applicable to it for the half year ended September 30, 2026.

By ScoutQuest · · 2 min read

Net worth (2025-26)
Rs. 9.25 crore
Paid-up equity capital (2025-26)
Rs. 2.28 crore
Net worth (2023-24)
Rs. 3.55 crore

What has been shared

The figures certified

What this means in simple terms

Regulation 23 sets the framework for how a listed company deals with its related parties — for example, transactions with promoters, group companies or key personnel — including approvals and disclosures. The update says these requirements do not currently apply to this company because of its SME listing and because its paid-up capital and net worth remain within the prescribed thresholds as on the last day of the previous financial year.

How to read this announcement

More numbers
  • Paid-up equity capital, FY 2025-262.28
  • Net worth, FY 2025-269.25
  • Paid-up equity capital, FY 2024-252.28
  • Net worth, FY 2024-258.83
  • Paid-up equity capital, FY 2023-241.68
  • Net worth, FY 2023-243.55
Source: BSE · 22 Oct 2026

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.

About ScoutQuest · Logos provided by Logo.dev